In more than 70 countries, Médecins Sans Frontières provides medical humanitarian assistance to save lives and ease the suffering of people in crisis situations.
We set up the MSF Access Campaign in 1999 to push for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond.
Based in Paris, CRASH conducts and directs studies and analysis of MSF actions. They participate in internal training sessions and assessment missions in the field.
Based in Geneva, UREPH (or Research Unit) aims to improve the way MSF projects are implemented in the field and to participate in critical thinking on humanitarian and medical action.
Based in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates.
This logistical and supply centre in Brussels provides storage of and delivers medical equipment, logistics and drugs for international purchases for MSF missions.
This supply and logistics centre in Bordeaux, France, provides warehousing and delivery of medical equipment, logistics and drugs for international purchases for MSF missions.
This logistical centre in Amsterdam purchases, tests, and stores equipment including vehicles, communications material, power supplies, water-processing facilities and nutritional supplements.
SAMU provides strategic, clinical and implementation support to various MSF projects with medical activities related to HIV and TB. This medical unit is based in Cape Town, South Africa.
BRAMU specialises in neglected tropical diseases, such as dengue and Chagas, and other infectious diseases. This medical unit is based in Rio de Janeiro, Brazil.
Our medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.
Providing epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.
Evaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work.
The Luxembourg Operational Research (LuxOR) unit coordinates field research projects and operational research training, and provides support for documentation activities and routine data collection.
The MSF Paediatric Days is an event for paediatric field staff, policy makers and academia to exchange ideas, align efforts, inspire and share frontline research to advance urgent paediatric issues of direct concern for the humanitarian field.
The MSF Foundation aims to create a fertile arena for logistics and medical knowledge-sharing to meet the needs of MSF and the humanitarian sector as a whole.
A collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.
We work with the Myanmar Ministry of Health to provide care for HIV and TB patients, primary healthcare, and vaccinations.
Once the largest provider of HIV treatment in Myanmar, we are working with the Ministry of Health and Sports to transfer patients to the decentralised National AIDS Programme so they can receive care closer to home. This includes patients on treatment for co-infections such as hepatitis C, tuberculosis (TB) and multidrug-resistant TB (MDR-TB).
We have mobile teams in Naga, Sagaing, a remote, mountainous region in northern Myanmar, where communities have limited access to basic healthcare, especially during the rainy season, when some may be completely inaccessible for months.
Despite restrictions on humanitarian access to conflict-affected areas and forcibly displaced people, we also have mobile teams based in Sittwe, central Rakhine, offering primary healthcare and arranging emergency referrals for patients from all communities.
Featured
International Activity Report 2018
The Rohingya: No country to call home
20 Jun 2019
In 2019
41,000
41,
outpatient consultations
15,100
15,1
people on first-line ARV treatment under direct MSF care
430
43
people started on treatment for TB
Myanmar
MSF teams bring immediate assistance, while additional staff and relief materials are ready to be sent
Press Release7 May 2008
Myanmar
MSF first response in Myanmar to Nargis cyclone
Project Update6 May 2008
Myanmar
In Myanmar, intimate HIV care is focus where isolation and rejection is the norm
Project Update5 Mar 2008
Neglected diseases
People with AIDS in southeast Asia needlessly becoming blind due to a neglected virus
Press Release30 Nov 2007
Myanmar
'Nobody should have to live like this'
Voices from the Field4 Jun 2007
Bangladesh
Myanmar refugees in Bangladesh: Stuck with nowhere to go
Press Release12 Mar 2007
Natural disasters
Asian tsunami: Overview of MSF activities in India, Thailand, Myanmar and Malaysia
Nearly 700,000 people died from AIDS, while 1.7 million people became newly infected with the HIV virus in 2019.
Medical Activities
Tuberculosis
Tuberculosis (TB) is one of the world’s biggest global health crises. Killing 1.4 million people in 2019, TB is the world’s deadliest infectious disease (WHO).
Medical Activities
Hepatitis C
Worldwide, an estimated 71 million people are infected with the hepatitis C virus, double the number living with HIV. While hepatitis C can be cured, few people have access to treatment.
In Focus
Rohingya refugee crisis
Since 25 August 2017, a massive exodus of over 706,000 Rohingya people have fled Myanmar. We are urging the Myanmar government for unfettered access to Rakhine state to ensure the impartial delivery of aid to those in need.
